| Dennis Stolpner, MD | |
|
1200 N. Tustin Ave, Suite 130, Santa Ana, CA 92705-3501 | |
| (657) 600-9077 | |
| (657) 600-9076 |
| Full Name | Dennis Stolpner |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Experience | 14 Years |
| Location | 1200 N. Tustin Ave, Santa Ana, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497018782 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 156847 (California) | Secondary |
| 208D00000X | General Practice | A156847 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Maximum Care Hospice, Inc | Valley village, CA | Hospice |
| Mission Community Hospital | Panorama city, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Innovative Medical Solutions Inc A Medical Group | 5294783080 | 24 |
| Ilya M Rachman Md Inc | 8628056728 | 3 |
News Archive
In the wake of Johns Hopkins' success in virtually eliminating intensive-care unit bloodstream infections via a simple five-step checklist, the safety scientist who developed and popularized the tool warns medical colleagues that they are no panacea.
The gut may need bacteria to provide a little bit of oxidative stress to stay healthy, new research suggests. Probiotic bacteria promote healing of the intestinal lining in mice by inducing the production of reactive oxygen species, researchers at Emory University School of Medicine have shown.
Megadyne, an end-to-end, full-solution electrosurgical equipment and accessory developer/manufacturer, announced today that it has entered into a one-year partnership with Attainia, an industry-leading online marketplace for medical capital equipment.
BIOTRONIK, Inc., announced today the U.S. launch of its new Reocor external pacemaker. The device is available in two models, for dual- and single-chamber pacing therapy, and offers individualized patient therapy, easy handling and flexibility in every detail. Reocor enriches BIOTRONIK's portfolio of high quality cardiovascular devices and sets a new standard of quality for external pacing therapy.
Ocera Therapeutics, Inc. presented an analysis of the prevalence of neurocognitive impairment in ambulatory cirrhotic patients. The data came from the screening period of the ASTUTE Study, an ongoing Phase 2b study evaluating the safety and efficacy of AST-120 (spherical carbon adsorbent) in the treatment of mild hepatic encephalopathy (MHE). The poster was presented yesterday at the annual meeting of the European Association for the Study of Liver (EASL) in Vienna, Austria. Efficacy and safety data from the ASTUTE study are expected in the summer of 2010.
› Verified 3 days ago
| Entity Name | Innovative Medical Solutions Inc A Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972624955 PECOS PAC ID: 5294783080 Enrollment ID: O20050107000871 |
News Archive
In the wake of Johns Hopkins' success in virtually eliminating intensive-care unit bloodstream infections via a simple five-step checklist, the safety scientist who developed and popularized the tool warns medical colleagues that they are no panacea.
The gut may need bacteria to provide a little bit of oxidative stress to stay healthy, new research suggests. Probiotic bacteria promote healing of the intestinal lining in mice by inducing the production of reactive oxygen species, researchers at Emory University School of Medicine have shown.
Megadyne, an end-to-end, full-solution electrosurgical equipment and accessory developer/manufacturer, announced today that it has entered into a one-year partnership with Attainia, an industry-leading online marketplace for medical capital equipment.
BIOTRONIK, Inc., announced today the U.S. launch of its new Reocor external pacemaker. The device is available in two models, for dual- and single-chamber pacing therapy, and offers individualized patient therapy, easy handling and flexibility in every detail. Reocor enriches BIOTRONIK's portfolio of high quality cardiovascular devices and sets a new standard of quality for external pacing therapy.
Ocera Therapeutics, Inc. presented an analysis of the prevalence of neurocognitive impairment in ambulatory cirrhotic patients. The data came from the screening period of the ASTUTE Study, an ongoing Phase 2b study evaluating the safety and efficacy of AST-120 (spherical carbon adsorbent) in the treatment of mild hepatic encephalopathy (MHE). The poster was presented yesterday at the annual meeting of the European Association for the Study of Liver (EASL) in Vienna, Austria. Efficacy and safety data from the ASTUTE study are expected in the summer of 2010.
› Verified 3 days ago
| Entity Name | Ilya M Rachman Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538487475 PECOS PAC ID: 8628056728 Enrollment ID: O20100924000926 |
News Archive
In the wake of Johns Hopkins' success in virtually eliminating intensive-care unit bloodstream infections via a simple five-step checklist, the safety scientist who developed and popularized the tool warns medical colleagues that they are no panacea.
The gut may need bacteria to provide a little bit of oxidative stress to stay healthy, new research suggests. Probiotic bacteria promote healing of the intestinal lining in mice by inducing the production of reactive oxygen species, researchers at Emory University School of Medicine have shown.
Megadyne, an end-to-end, full-solution electrosurgical equipment and accessory developer/manufacturer, announced today that it has entered into a one-year partnership with Attainia, an industry-leading online marketplace for medical capital equipment.
BIOTRONIK, Inc., announced today the U.S. launch of its new Reocor external pacemaker. The device is available in two models, for dual- and single-chamber pacing therapy, and offers individualized patient therapy, easy handling and flexibility in every detail. Reocor enriches BIOTRONIK's portfolio of high quality cardiovascular devices and sets a new standard of quality for external pacing therapy.
Ocera Therapeutics, Inc. presented an analysis of the prevalence of neurocognitive impairment in ambulatory cirrhotic patients. The data came from the screening period of the ASTUTE Study, an ongoing Phase 2b study evaluating the safety and efficacy of AST-120 (spherical carbon adsorbent) in the treatment of mild hepatic encephalopathy (MHE). The poster was presented yesterday at the annual meeting of the European Association for the Study of Liver (EASL) in Vienna, Austria. Efficacy and safety data from the ASTUTE study are expected in the summer of 2010.
› Verified 3 days ago
| Entity Name | Outreach Care Medical Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285976787 PECOS PAC ID: 9234375569 Enrollment ID: O20130411000337 |
News Archive
In the wake of Johns Hopkins' success in virtually eliminating intensive-care unit bloodstream infections via a simple five-step checklist, the safety scientist who developed and popularized the tool warns medical colleagues that they are no panacea.
The gut may need bacteria to provide a little bit of oxidative stress to stay healthy, new research suggests. Probiotic bacteria promote healing of the intestinal lining in mice by inducing the production of reactive oxygen species, researchers at Emory University School of Medicine have shown.
Megadyne, an end-to-end, full-solution electrosurgical equipment and accessory developer/manufacturer, announced today that it has entered into a one-year partnership with Attainia, an industry-leading online marketplace for medical capital equipment.
BIOTRONIK, Inc., announced today the U.S. launch of its new Reocor external pacemaker. The device is available in two models, for dual- and single-chamber pacing therapy, and offers individualized patient therapy, easy handling and flexibility in every detail. Reocor enriches BIOTRONIK's portfolio of high quality cardiovascular devices and sets a new standard of quality for external pacing therapy.
Ocera Therapeutics, Inc. presented an analysis of the prevalence of neurocognitive impairment in ambulatory cirrhotic patients. The data came from the screening period of the ASTUTE Study, an ongoing Phase 2b study evaluating the safety and efficacy of AST-120 (spherical carbon adsorbent) in the treatment of mild hepatic encephalopathy (MHE). The poster was presented yesterday at the annual meeting of the European Association for the Study of Liver (EASL) in Vienna, Austria. Efficacy and safety data from the ASTUTE study are expected in the summer of 2010.
› Verified 3 days ago
| Entity Name | Dennis Stolpner Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417638768 PECOS PAC ID: 9335594464 Enrollment ID: O20231010003146 |
News Archive
In the wake of Johns Hopkins' success in virtually eliminating intensive-care unit bloodstream infections via a simple five-step checklist, the safety scientist who developed and popularized the tool warns medical colleagues that they are no panacea.
The gut may need bacteria to provide a little bit of oxidative stress to stay healthy, new research suggests. Probiotic bacteria promote healing of the intestinal lining in mice by inducing the production of reactive oxygen species, researchers at Emory University School of Medicine have shown.
Megadyne, an end-to-end, full-solution electrosurgical equipment and accessory developer/manufacturer, announced today that it has entered into a one-year partnership with Attainia, an industry-leading online marketplace for medical capital equipment.
BIOTRONIK, Inc., announced today the U.S. launch of its new Reocor external pacemaker. The device is available in two models, for dual- and single-chamber pacing therapy, and offers individualized patient therapy, easy handling and flexibility in every detail. Reocor enriches BIOTRONIK's portfolio of high quality cardiovascular devices and sets a new standard of quality for external pacing therapy.
Ocera Therapeutics, Inc. presented an analysis of the prevalence of neurocognitive impairment in ambulatory cirrhotic patients. The data came from the screening period of the ASTUTE Study, an ongoing Phase 2b study evaluating the safety and efficacy of AST-120 (spherical carbon adsorbent) in the treatment of mild hepatic encephalopathy (MHE). The poster was presented yesterday at the annual meeting of the European Association for the Study of Liver (EASL) in Vienna, Austria. Efficacy and safety data from the ASTUTE study are expected in the summer of 2010.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dennis Stolpner, MD 2171 S. El Camino Real, Suite 104, Oceanside, CA 92054-6269 Ph: (760) 754-5663 | Dennis Stolpner, MD 1200 N. Tustin Ave, Suite 130, Santa Ana, CA 92705-3501 Ph: (657) 600-9077 |
News Archive
In the wake of Johns Hopkins' success in virtually eliminating intensive-care unit bloodstream infections via a simple five-step checklist, the safety scientist who developed and popularized the tool warns medical colleagues that they are no panacea.
The gut may need bacteria to provide a little bit of oxidative stress to stay healthy, new research suggests. Probiotic bacteria promote healing of the intestinal lining in mice by inducing the production of reactive oxygen species, researchers at Emory University School of Medicine have shown.
Megadyne, an end-to-end, full-solution electrosurgical equipment and accessory developer/manufacturer, announced today that it has entered into a one-year partnership with Attainia, an industry-leading online marketplace for medical capital equipment.
BIOTRONIK, Inc., announced today the U.S. launch of its new Reocor external pacemaker. The device is available in two models, for dual- and single-chamber pacing therapy, and offers individualized patient therapy, easy handling and flexibility in every detail. Reocor enriches BIOTRONIK's portfolio of high quality cardiovascular devices and sets a new standard of quality for external pacing therapy.
Ocera Therapeutics, Inc. presented an analysis of the prevalence of neurocognitive impairment in ambulatory cirrhotic patients. The data came from the screening period of the ASTUTE Study, an ongoing Phase 2b study evaluating the safety and efficacy of AST-120 (spherical carbon adsorbent) in the treatment of mild hepatic encephalopathy (MHE). The poster was presented yesterday at the annual meeting of the European Association for the Study of Liver (EASL) in Vienna, Austria. Efficacy and safety data from the ASTUTE study are expected in the summer of 2010.
› Verified 3 days ago
David Chen, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 719 E 1st St Ste C, Santa Ana, CA 92701 Phone: 714-547-0104 Fax: 714-973-8612 | |
Dr. Scott Alan Wilchek, D.O. General Practice Medicare: Accepting Medicare Assignments Practice Location: 1800 Old Tustin Ave, Santa Ana, CA 92705 Phone: 714-835-4900 | |
Yoonhee Hong Choi, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 1241 E Dyer Rd Ste 145, Santa Ana, CA 92705 Phone: 949-449-1112 | |
Dr. Marco M Zahedi, M.D., M.P.H. General Practice Medicare: Accepting Medicare Assignments Practice Location: 1200 N Tustin Ave Ste 120, Santa Ana, CA 92705 Phone: 949-371-9862 Fax: 866-439-4879 | |
Dr. Joseph Anthony Serna, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 2620 S Bristol St Ste B, Santa Ana, CA 92704 Phone: 714-545-5503 Fax: 714-545-5509 | |
Dr. Paris Sabo, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 2700 S Bristol St, Santa Ana, CA 92704 Phone: 949-423-6011 | |
David A Sanchez, MD General Practice Medicare: Medicare Enrolled Practice Location: 1614 French St, Santa Ana, CA 92701 Phone: 714-480-6800 Fax: 714-480-9285 |